Announcements

Benjamin Louis Kirchhoff, Chief Accounting Officer of Samsara Inc. (NYSE:IOT), filed a Form 4 on September 21, 2026, reporting the sale of 770 shares of Class A Common Stock on September 18, 2026.

Molly D Kannan, Chief Accounting Officer and Corporate Controller of Ryerson Holding Corp, filed a Form 4 on September 21, 2026, disclosing the acquisition of restricted stock unit dividend equivalent rights on September 17, 2026.

A Form 4 filed on September 21, 2026 disclosed that Prakash Raman, a director of Black Diamond Therapeutics, Inc. (NASDAQ:BDTX), acquired 6,801 shares of common stock on September 18, 2026, in lieu of cash compensation under the company's non-employee director compensation policy.

Director Ali Behbahani filed a Form 4 with the SEC on September 21, 2026, reporting the acquisition of Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) common stock on September 18, 2026, in lieu of cash compensation for board service.

A Form 4 filed with the SEC on September 21, 2026, discloses that Hope F. Cochran, a director of MongoDB, Inc. (NASDAQ:MDB), sold 1,000 shares of common stock on September 17, 2026, pursuant to a Rule 10b5-1 trading plan.

Vincent Roche, Chair and CEO of Analog Devices Inc (NASDAQ:ADI), filed a Form 4 on September 21, 2026, disclosing a gift of 19,200 shares of common stock to the Roche Family Foundation Inc. on September 18, 2026.

A Form 4 filed with the SEC on September 21, 2026, disclosed that Kevin J. Buchi, a director of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX), transferred 20,445 shares of Class A Common Stock to a trust on September 17, 2026, for no consideration.